Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Pharem Biotech AB
AB
Active
Org 5569230955
Kistagången 12, 164 40
Kista
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2013 · 13 years old
6 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Pharem Biotech AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
2M
3M
5M
7M
1M
2020
1M
2021
2M
2022
3M
2023
6M
2024
EBITDA
SEK millions
3M
1M
0M
-1M
-3M
2M
2020
-1M
-150%
2021
-2M
-100%
2022
1M
+150%
2023
1M
0%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
881
516
1 680
3 361
5 695
Staff expenses
—
—
—
—
—
EBITDA
1 981
−961
−2 188
1 052
1 093
Depreciation & amort.
−69
−5 322
−5 269
−5 123
−5 135
EBIT
1 912
−6 283
−7 457
−4 071
−4 042
Net financials
−50
−28
−233
−522
−349
Profit before tax
1 862
−6 312
−7 690
−4 593
−4 392
Tax
−0
−0
−0
−0
−0
Net profit
1 862
−6 312
−7 690
−4 593
−4 392
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
29 447
34 778
22 314
16 905
9 596
Equity
10 038
16 207
8 517
7 006
2 614
Long-term debt
405
8 926
5 087
0
0
Short-term debt
19 005
9 645
8 709
9 899
6 982
Total debt
19 410
18 571
13 796
9 899
6 982
Financial ratios
5-year trend
EBITDA-margin
19.2%
This company
15.8%
Market median
+22% vs market
2020
2024
Soliditetsgrad
27.2%
This company
38.2%
Market median
-29% vs market
2020
2024
Egenkapitalforrentning
-168.0%
This company
18.4%
Market median
-1013% vs market
2020
2024
Nettoresultatgrad
-77.1%
This company
8.1%
Market median
-1052% vs market
2020
2024
Aktivomsætning
0.59×
This company
1.12×
Market median
-47% vs market
2020
2024
Gæld/egenkapital
2.67×
This company
0.62×
Market median
-331% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Pharem Biotech AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
